Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion.
- Mc Zatelli
- , D Piccin
- , C Vignali
- , F Tagliati
- , Ambrosio
- , M Bondanelli
- , V Cimino
- , Antonio Bianchi
- , Ha Schmid
- , M Scanarini
- , Alfredo Pontecorvi
- , Laura De Marinis Grasso
- , Giulio Maira
- , E. c. Degli Uberti
Research output: Contribution to journal › Article
89
Link opens in a new tab
Citations
(Scopus)